Activity of human p450 2D6 in biphasic solvent systems

被引:6
|
作者
Zhao, Jin [1 ]
Tan, Elaine [1 ]
Ferras, Julian [1 ]
Auclair, Karine [1 ]
机构
[1] McGill Univ, Dept Chem, Montreal, PQ H3A 2K6, Canada
关键词
biocatalyst; biphasic; CYP; hydroxylation; organic solvent;
D O I
10.1002/bit.21449
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Several limitations have restricted the use of P450 enzymes in synthesis, including the narrow substrate specificity of some P450 isoforms, the need for a redox partner and an expensive cofactor, incompatibility with organic solvents, and poor stability. We previously demonstrated that the natural redox partner and cofactor of the promiscuous P450s 3A4 and 2D6 can be efficiently substituted with some cheap hydrogen peroxide donors or organic peroxides. We report here that P450 2D6 maintains as much as 76% of its activity when used in buffer/organic emulsions. Product formation in biphasic solvent systems is comparable whether the natural redox partner and cofactor are used, or a surrogate. As reported for the enzymes, a correlation is observed between the logP and suitability of a solvent for enzymatic activity. Moreover, the utility of our system was established by demonstrating the transformation of a novel hydrophobic substrate, not modified by P450 2D6 in the absence of organic solvent.
引用
收藏
页码:508 / 513
页数:6
相关论文
共 50 条
  • [21] Design and synthesis of fluorescent probes for human cytochrome P450 2D6
    Hanna, IH
    Cai, H
    Guengerich, FP
    FASEB JOURNAL, 1999, 13 (07): : A1347 - A1347
  • [22] Cytochrome P450 2A6 meets P450 2D6: an enigma of viral infections and autoimmunity
    Bogdanos, DP
    McFarlane, IG
    JOURNAL OF HEPATOLOGY, 2003, 39 (05) : 860 - 863
  • [23] The endocannabinoid anandamide is a substrate of cytochrome P450 2D6
    Snider, Natasha Tasheva
    Sridar, Chitra
    Hollenberg, Paul
    FASEB JOURNAL, 2008, 22
  • [24] Hot flushes, tamoxifen and cytochrome P450 2D6
    Boutet, G.
    ONCOLOGIE, 2012, 14 (6-7) : 357 - 364
  • [25] Oxidation of methoxytyramines by recombinant cytochrome P450 2D6
    Hanna, IH
    Nishimura, Y
    Miller, GP
    Rizzo, CJ
    Guengerich, FP
    FASEB JOURNAL, 2000, 14 (08): : A1335 - A1335
  • [26] A DISCORDANCE BETWEEN P450 2D6 GENOTYPE AND PHENOTYPE
    Duricova, J.
    Perinova, I
    Kacirova, I
    Grundmann, M.
    Jeziskova, I
    Jurckova, N.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 75 - 75
  • [27] Cytochrome P450 2D6 genetic polymorphisms of ugandans
    Miura, I.
    Saito, K.
    Obua, C.
    Abbo, C.
    Kaneko, S.
    Tateishi, T.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 103 - 103
  • [28] The role of cytochrome P450 2D6 in the metabolism of moclobemide
    Hartter, S
    Dingemanse, J
    Baier, D
    Ziegler, G
    Hiemke, C
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1996, 6 (03) : 225 - 230
  • [29] Cytochrome P450 2D6 and treatment of codeine dependence
    Romach, MK
    Otton, SV
    Somer, G
    Tyndale, RF
    Sellers, EM
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2000, 20 (01) : 43 - 45
  • [30] Cytochrome P450 2D6 polymorphism and character traits
    Suzuki, E
    Kitao, Y
    Ono, Y
    Iijima, Y
    Inada, T
    PSYCHIATRIC GENETICS, 2003, 13 (02) : 111 - 113